CytoMed Therapeutics
GDTC
#9580
Rank
HK$0.20 B
Marketcap
HK$17.36
Share price
-0.45%
Change (1 day)
-39.80%
Change (1 year)

Revenue for CytoMed Therapeutics (GDTC)

Revenue in 2022: N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytoMed Therapeutics from 2020 to 2022

Annual revenue

Year Revenue Change
2022N/A
2021N/A
2020N/A